CoChat
Sign Up
Cited by 116Psychedelics and Drug StudiesHistorical Psychiatry and Medical PracticesPsychotherapy Techniques and Applications

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

The early use of MDMA (‘Ecstasy') in Psychotherapy (1977–1985)

Open access
Passie, Torsten·2018·Drug Science Policy and Law
DOI 10.1177/2050324518767442
Open this paper in CoChat — free accountOpen PDF

Abstract

3,4-Methylenedioxymethamphetamine (MDMA), also known as ecstasy, was first synthesized in 1912 but first reached widespread popularity as a legal alternative after the much sought-after recreational drug 3,4-methylenedioxy-amphetamine (MDA) was made illegal in 1970. Because of its benign, feeling-enhancing, and nonhallucinatory properties, MDMA was used by a few dozen psychotherapists in the United States between 1977 and 1985, when it was still legal. This article looks into the contexts and practices of its psychotherapeutic use during these years. Some of the guidelines, recommendations, and precautions developed then are similar to those that apply to psychedelic drugs, but others are specific for MDMA. It is evident from this review that the therapists pioneering the use of MDMA were able to develop techniques (and indications/counterindications) for individual and group therapy that laid the groundwork for the use of MDMA in later scientific studies. In retrospect, it appears that the perceived beneficial effects of MDMA supported a revival of psycholytic/psychedelic therapy on an international scale.

Overview

Integrity signals

Registry

Crossref · 10.1177/2050324518767442

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Research works printed but not linked: 56

  1. Adamson S, 1985, Through the Gateway of the Heart
  2. Adamson S, 1985, Through the Gateway of the Heart, 181
  3. Adamson S, 1988, ReVision: A Journal of Consciousness and Transformation, 10, 59
  4. Adler J, 1985, Newsweek Magazine
  5. Alles GA, 1959, Neuropharmacology, 181
  6. Andrew, 2004, The Secret Chief Revealed, 135
  7. Anonymous, 1985, MDMA – A Multidisciplinary Investigation, 187
  8. Association for the Responsible Use of Psychedelic Agents, 1984, (1985) MDMA – A Multidisciplinary Investigation, 362
  9. Caldwell WV, 1968, LSD Psychotherapy
  10. Collin M, 1998, Altered States: The Story of Ecstasy Culture and Acid House
  11. Cotton R, 1985, MDMA – A Multidisciplinary Investigation, 286
  12. Dass R [=Alpert R], 2010, The Birth of a Psychedelic Culture
  13. Doblin R (2000) Regulation of the Medical Use of Psychedelics and Marijuana. Cambridge, MA: Harvard University, PhD Dissertation. Available at: www.maps.org/doblin-dissertation (accessed 7 July 2016).
  14. Doblin R, 2001, Ecstasy: The Complete Guide, 369
  15. Doblin R, 2012, Catalyst of miracles: The unknown Claudio Naranjo, 143
  16. Downing J, 1986, Individual Revitalization Training: Counselors Manual
  17. Earth Metabolic Design Laboratories, 1985, MDMA – A Multidisciplinary Investigation, 5
  18. Earth Metabolic Design Laboratories, 1985, MDMA – A Multidisciplinary Investigation, 7
  19. Eisner B, 1989, MDMA: The Ecstasy Story
  20. Gasser P, 1996, Schweizer Archiv für Neurologie und Psychiatrie, 147, 59
  21. Gertz KR, 1985, Harper’s Bazaar
  22. Greer G, 1983, MDMA: A New Psychoactive Compound and Its Effects in Humans
  23. Greer G, 1985, Advances, 2, 57
  24. Greer G, 1985, MDMA – Die neue Sympathiedroge, 28
  25. Greer G, 2001, MDMA: The Complete Guide, 222
  26. Greer G, 1985, MDMA – A Multidisciplinary Investigation, 190
  27. Grof S, 1980, LSD Psychotherapy
  28. Harlow D, 1994, Ecstasy, 237
  29. Harlow D, 1997, Ecstasy Reconsidered, 173
  30. Harlow D, 2013, Interview by Torsten Passie
  31. Ingrasci R, 2016, Interview with Torsten Passie
  32. Metzner R, 1998, MAPS Bulletin, 8, 39
  33. Metzner R, 2011, MAPS Bulletin, 21, 9
  34. Metzner R, 2013, Interview by Torsten Passie
  35. Naranjo C, 1986, Symposion Über den aktuellen Stand der Forschung auf dem Gebiet der psychoaktiven Substanzen, 168
  36. Naranjo C (1989) MDMA in group therapy. In: Eisner B (ed.), Ecstasy: The MDMA Story . Berkeley, CA: Ronin, pp.107–111.
  37. Naranjo C, 2001, Ecstasy: The Complete Guide, 208
  38. Naranjo C, 1967, Medicina Et Pharmacologia Experimentalis. International Journal of Experimental Medicine, 17, 359
  39. Passie T, 1992, Yearbook of the European College for the Study of Consciousness, 1992, 103
  40. Passie T, 1997, Psycholytic and Psychedelic Therapy Research 1931–1995: A Complete International Bibliography
  41. Passie T, 2012, Healing with Entactogens
  42. Perry JW, 1974, The Far Side of Madness
  43. Philipps D, 2016, New York Times
  44. Richards RN, 1972, Canadian Medical Association Journal, 106, 256
  45. Sargent T, 2013, Interview by Torsten Passie
  46. Saunders N, 1997, Ecstasy Reconsidered
  47. Scharfetter C, 1994, Bulletin of the Multidisciplinary Association for Psychedelic Studies, 4
  48. Seymour, 1986, MDMA
  49. Shafer J, 1985, Psychology Today
  50. Shulgin A, 1984, (1985) MDMA – A Multidisciplinary Investigation, 187
  51. Shulgin AS, 2004, (2004) The Secret Chief Revealed, 17
  52. Shulgin AT, 1967, Ethnopharmacological Search for Psychoactive Drugs, 202
  53. Shulgin AT, 1995, Voices from the Edge, 124
  54. Shulgin AT, 2005, Higher Wisdom, 69
  55. Stolaroff M, 2004, The Secret Chief Revealed
  56. Styk J, 1994, Welten des Bewusstseins, 4, 149

Cited by

Sorted by citations

See all 116

Related

Metadata

Authors
Passie, T.
Affiliations
Goethe University Frankfurt (DE)
Corresponding author
Passie, Torsten
ORCID
Passie, Torsten
Venue
Drug Science Policy and Law
Publisher
SAGE Publications
Published
2018-01
Volume
4
ISSN
2050-3245 (ISSN-L)
DOI
10.1177/2050324518767442
OpenAlex
W2797335301
Cited by
116
References
29
Citations by year
2026: 5 · 2025: 13 · 2024: 28 · 2023: 35 · 2022: 17 · 2021: 9 · 2020: 5 · 2019: 2 · 2018: 2
FWCI
5.29
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
Drug Science Policy and Law (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Psychology › Clinical Psychology › Historical Psychiatry and Medical Practices
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords
MDMA, ecstasy, psychotherapy, psychedelic therapy, history of psychotherapy, group therapy, individual psychotherapy, 1970s, 3,4-methylenedioxyamphetamine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review